Alzheimer's Disease

Health and Research – Other

Low Heart Rate and Blood Pressure

Blood pressure and heart rates/pulses that are on the lower end of normal or even…

Rigsby RigsbyMarch 9, 2022

Health and Research – Alzheimer's/Dementia

How is Alzheimer’s disease diagnosed in a person with Down syndrome?

Alzheimer’s disease is a progressive neurological condition. It is a type of dementia. Alzheimer’s disease…

Rigsby RigsbyMarch 8, 2022

Healthy Living

8 Tips to Promote Healthy Sleep Habits for People with Down Syndrome

Sleep disorders frequently affect individuals with Down syndrome. Growing evidence suggests that sleep disruption may…

Rigsby RigsbyFebruary 8, 2022

Health and Research – Alzheimer's/Dementia

The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix

Dr. Marcia Ratner & Dr. James Hendrix discuss recent developments in Alzheimer’s research.Source: Dr. Marcia…

Rigsby RigsbyDecember 3, 2021

Health and Research – Alzheimer's/Dementia

Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs

This blogpost from a former FDA insider on the power of the patient helps us…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

LuMind IDSC signs on to NTG statement re: Aduhelm

“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage

LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The National Task Group…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003

Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease

The NTG brought together a national panel of expert researchers and practitioners in the field…

Rigsby RigsbyOctober 20, 2021

Alzheimer’s Disease

Low Heart Rate and Blood Pressure

How is Alzheimer’s disease diagnosed in a person with Down syndrome?

8 Tips to Promote Healthy Sleep Habits for People with Down Syndrome

The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix

Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

LuMind IDSC signs on to NTG statement re: Aduhelm

LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage

FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003

Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease

CONTACT LUMIND IDSC

QUICK LINKS

JOIN US